Short answer
CorMedix Inc. (CRMD) filed an 8-K current report with the SEC on July 2, 2026 reporting Item 8.01 (Other Events). Elizabeth Hurlburt promoted to Chief Operating and Commercial Officer on June 29, 2026.
CorMedix Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Elizabeth Hurlburt promoted to Chief Operating and Commercial Officer on June 29, 2026
- Expanded remit covers commercial functions, medical affairs, regulatory and clinical operations
- Michael Seckler departed the Company as part of the leadership restructuring
- Hurlburt continues reporting to Chairman and CEO Joseph Todisco, preserving centralized executive oversight
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CorMedix Inc. 8-K filings
Get the next CRMD 8-K as it lands
Follow CRMD for push alerts, or ask the research agent what this filing means.